Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy

Aim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Materials and methods. The open longitudinal study in...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Nozdricheva, I. B. Lysenko, N. K. Guskova, N. V. Nikolaeva, Ya. S. Gaysultanova, S. N. Dimitriadi, O. G. Ishonina
Format: Article
Language:Russian
Published: ABV-press 2024-04-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/924
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839574375721861120
author A. S. Nozdricheva
I. B. Lysenko
N. K. Guskova
N. V. Nikolaeva
Ya. S. Gaysultanova
S. N. Dimitriadi
O. G. Ishonina
author_facet A. S. Nozdricheva
I. B. Lysenko
N. K. Guskova
N. V. Nikolaeva
Ya. S. Gaysultanova
S. N. Dimitriadi
O. G. Ishonina
author_sort A. S. Nozdricheva
collection DOAJ
description Aim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Materials and methods. The open longitudinal study included 39 patients with newly diagnosed diffuse large B-cell lymphoma who received specialized treatment at the Oncohematology Department of National Medical Research Centre for Oncology (Rostov-on-Don) in 2021. Patients received induction immunochemotherapy according to the R-CHOP regimen (rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone) in combination with accompanying therapy (allopurinol 300 mg/day). Blood sampling was carried out at 0, 24, 48, 72, 120 hours and on 21st day of the 1st therapy cycle. Patients were divided into 2 groups depending on the GFR level, calculated by creatinine, before treatment: group A – 27 (69 %) patients with GFR >90 ml/min/1.73 m2, group B – 12 (31 %) patients with GFR <90 ml/min/1.73 m2.Results. During the immunochemotherapy in patients with initially reduced GFR, a further decrease was observed with the restoration of the initial level by day 21 of therapy. When calculating GFR by cystatin C, in contrast to the calculation by creatinine, it revealed the dependence of GFR level on pathological process stage: GFR in group A patients with stages I–II is 20.4 % lower than in patients with stages III–IV, in group B – by 30.5 %. The use of the fisher test at GFR thresholds of 90 and 60 ml/min/1.73 m2 revealed a greater advantage in establishing absolute GFR levels, especially in the range of 60 to 90 ml/min/1.73 m2.Conclusion. The data obtained confirm that the determination of GFR by cystatin C in patients with diffuse large B-cell lymphoma is a more sensitive method that objectively reflects the functional state of the kidneys, especially when values are within the “gray area” – from 90 to 60 ml/min/1.73 m2.
format Article
id doaj-art-85e037c77f8b4d01b5ad06b26fa83ea9
institution Matheson Library
issn 1818-8346
2413-4023
language Russian
publishDate 2024-04-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-85e037c77f8b4d01b5ad06b26fa83ea92025-08-04T13:57:54ZrusABV-pressОнкогематология1818-83462413-40232024-04-01192677410.17650/1818-8346-2024-19-2-67-74760Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapyA. S. Nozdricheva0I. B. Lysenko1N. K. Guskova2N. V. Nikolaeva3Ya. S. Gaysultanova4S. N. Dimitriadi5O. G. Ishonina6National Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaNational Medical Research Centre for Oncology, Ministry of Health of RussiaAim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Materials and methods. The open longitudinal study included 39 patients with newly diagnosed diffuse large B-cell lymphoma who received specialized treatment at the Oncohematology Department of National Medical Research Centre for Oncology (Rostov-on-Don) in 2021. Patients received induction immunochemotherapy according to the R-CHOP regimen (rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone) in combination with accompanying therapy (allopurinol 300 mg/day). Blood sampling was carried out at 0, 24, 48, 72, 120 hours and on 21st day of the 1st therapy cycle. Patients were divided into 2 groups depending on the GFR level, calculated by creatinine, before treatment: group A – 27 (69 %) patients with GFR >90 ml/min/1.73 m2, group B – 12 (31 %) patients with GFR <90 ml/min/1.73 m2.Results. During the immunochemotherapy in patients with initially reduced GFR, a further decrease was observed with the restoration of the initial level by day 21 of therapy. When calculating GFR by cystatin C, in contrast to the calculation by creatinine, it revealed the dependence of GFR level on pathological process stage: GFR in group A patients with stages I–II is 20.4 % lower than in patients with stages III–IV, in group B – by 30.5 %. The use of the fisher test at GFR thresholds of 90 and 60 ml/min/1.73 m2 revealed a greater advantage in establishing absolute GFR levels, especially in the range of 60 to 90 ml/min/1.73 m2.Conclusion. The data obtained confirm that the determination of GFR by cystatin C in patients with diffuse large B-cell lymphoma is a more sensitive method that objectively reflects the functional state of the kidneys, especially when values are within the “gray area” – from 90 to 60 ml/min/1.73 m2.https://oncohematology.abvpress.ru/ongm/article/view/924diffuse large b-cell lymphomaimmunochemotherapyr-chopglomerular filtration raterenal dysfunctioncreatininecystatin c
spellingShingle A. S. Nozdricheva
I. B. Lysenko
N. K. Guskova
N. V. Nikolaeva
Ya. S. Gaysultanova
S. N. Dimitriadi
O. G. Ishonina
Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
Онкогематология
diffuse large b-cell lymphoma
immunochemotherapy
r-chop
glomerular filtration rate
renal dysfunction
creatinine
cystatin c
title Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
title_full Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
title_fullStr Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
title_full_unstemmed Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
title_short Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
title_sort objectification of the method for glomerular filtration rate assessing in patients with diffuse large b cell lymphoma during induction immunochemotherapy
topic diffuse large b-cell lymphoma
immunochemotherapy
r-chop
glomerular filtration rate
renal dysfunction
creatinine
cystatin c
url https://oncohematology.abvpress.ru/ongm/article/view/924
work_keys_str_mv AT asnozdricheva objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT iblysenko objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT nkguskova objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT nvnikolaeva objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT yasgaysultanova objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT sndimitriadi objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy
AT ogishonina objectificationofthemethodforglomerularfiltrationrateassessinginpatientswithdiffuselargebcelllymphomaduringinductionimmunochemotherapy